000 | 02039nam a22001937a 4500 | ||
---|---|---|---|
999 |
_c53519 _d53519 |
||
005 | 20220603090327.0 | ||
008 | 211125b ||||| |||| 00| 0 eng d | ||
020 | _a0-444-90148-5 | ||
040 |
_cUEES _eRCAA2 |
||
041 | 0 | _aeng | |
082 |
_a616.399 5 _bC567p |
||
110 | 2 |
_aCiba Foundation _eAut. _976324 |
|
245 |
_aProtein degradation in health and disease / _cCiba Foundation |
||
300 |
_a417 p. : _bgráf. ; _c25 cm. x 17 cm. |
||
505 | _aIntroduction: the clasification of proteinases -- Lysocomal cysteine proteinases -- Cathepsin D: the lysosomal aspartic proteinase -- Human leucocyte elastase and cathepsin G: structural and functional characteristics -- Human collagenases: comparative and inmunolocalization studies -- Proteinases in connective tissue breakdown -- Cellular mechanisms of proteinase release from inflamatory cells and the degradation of extracellular proteins -- Inactivation of cytosol enzymes by a liver membrane protein -- Lysosomes and protein degradation -- Insigths into mechanisms of intracellular protein turnover from studies on pinocytosis -- Turnover and degradation of mitochondria and their proteins -- Protein degradation in cells in culture -- Regulation of protein breakdown in hepatocyte monolayers -- A possible role for neutral proteolysis in the degradation of intracellular proteins -- Studies of the ATP dependence of protein degradation in cells and cell extracts -- Coordination of protein synthesis and degradation -- Application of liver perfusion as an in vitro model in studies of intracellular protein degradation -- Protein degradation and the regulation of protein balance in muscle -- Protein degradation in metabolic and nutritional disorders -- Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxaemia): biochemical, pathophysiological and therapeutic aspects -- Neutral proteinases of leucocytes and the inflammatory process -- Concluding remarks. | ||
650 | 0 | 7 |
_2LEMB _aPROTEINAS _976325 |
942 |
_2ddc _cBK |